Atlas Trials

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Clinical trial NCT02640222 · COMPLETED

Trial details

NCT number
NCT02640222
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Anticoagulation
Start date
2014-01-01
Primary completion
2016-12-31
Enrollment
321501

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.